SKU: LIP-WEGOVY-17

Wegovy 1.7mg

Wegovy 1.7 mg is designed for people who have advanced through the lower doses and are ready for a more intensive level of treatment.

This higher dose, part of the FDA-approved regimen, enhances the effect of the medication on appetite regulation, allowing more significant weight loss while maintaining a manageable side-effect profile.

The 1.7 mg dose follows Wegovy’s scientifically backed treatment protocol, which emphasizes gradual dose escalation to maximize results.

By reaching this phase, you are demonstrating commitment to obtaining transformative results for your health.

Active Ingredient

Semaglutide

Composition

Semaglutide 1.7 mg

Packaging

1 prefilled pen with 4 weekly doses; 4 disposable needles; 1 instruction manual

Wholesale price $372.00

Add to quote

Description

Wegovy 1.7 mg is an advanced phase in the FDA-approved weight-management program. This dose enhances the effects of the medication, being ideal for people advancing in their treatment process. It is suitable for adults with obesity (BMI ≥30) or overweight (BMI ≥27 with related health conditions). Wegovy 1.7 mg helps accelerate weight loss and maintain the progress achieved.

How does Wegovy work?

Provides more significant appetite regulation to enhance weight loss
Reduces caloric intake by means of slower gastric emptying
Supports gradual and sustainable progress when combined with a healthy lifestyle

How to use

Inject subcutaneously once a week in the abdomen, thigh or upper arm
Follow the schedule prescribed by the health professional for safe and effective use

Precautions

Do not use Wegovy if you are pregnant, breastfeeding, or if you have a personal or family history of thyroid carcinoma or MEN 2
Consult a doctor if you present underlying health conditions such as pancreatitis, diabetes or retinopathy